Robatumumab (IGF1R/CD221) - Research Grade Biosimilar
Product Specifications
Background
Robatumumab has been used in trials studying the treatment of Osteosarcoma, Sarcoma, Ewing's, and Peripheral Neuroectodermal Tumor.
Immunogen
Homo sapiens / IGF1R/CD221 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
19D12, SCH 717454
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882287-500 1x 500 µL
SOX9 / SRY-box 9 (SOX9/2287R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-I873000-10G 10 g
Isopropyl ß-D-Thiogalactopyranoside, Dioxane Free
Sign In for Pricing
View Details 
BNC742242-100 1x 100 µL
Glutathione S-Transferase Mu2 (GSTM2) (CPTC-GSTMu2-2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
